HECN30227 not checked
Sunshine Lake Pharma Co., Ltd.
FollowEvery change as it happens, and a Monday email
Trials
1 active
1 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- HBV Infection
- Main trialPhase 1
- “To evaluate the safety, efficacy, pharmacokinetics and immunogenicity of single and multiple doses of HECN30227 Injection in healthy volunteers and patients with chronic hepatitis B”In the company’s words, NCT07771140 on ClinicalTrials.gov
Other drugs for HBV Infection
- GST-HG141Fujian Akeylink Biotechnology Co., Ltd. · Phase 3
- AHB-137Ausper Biopharma Co., Ltd. · Phase 3
- In-House Recombinant Hepatitis B vaccinePT Bio Farma · Phase 3
- ZM-H1505RShanghai Zhimeng Biopharma, Inc. · Phase 3
- LBVDLG Chem · Phase 2/3
- TQA3605Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Phase 3
Coming up1
- 11 Apr 2027Phase 1 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1Recruiting | 11 Apr 2027 | A Phase I Clinical Trial to Evaluate HECN30227 Injection in Healthy Subjects and Subjects With Chronic Hepatitis B |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026